Select dietary phytochemicals function as inhibitors of COX-1 but not COX-2

Area of Science:

• Biochemistry
• Pharmacology
• Nutritional Science

Background:

• Selective cyclooxygenase-2 (COX-2) inhibitors have raised cardiovascular safety concerns in clinical trials.
• Many dietary phytochemicals are known to target COX-2 and suppress carcinogenesis.
• A discrepancy exists between the cardiovascular safety of phytochemicals and COX-2 inhibitors, prompting investigation.

Purpose of the Study:

• To evaluate the potential cardiovascular toxicity of dietary-derived phytochemicals.
• To elucidate the mechanism behind the apparent cardiovascular safety of phytochemicals despite potential COX-2 inhibition.

Main Methods:

• A library of dietary phytochemicals was screened for cardiovascular toxicity.
• Human umbilical vein endothelial cells were used as an in vitro model.
• Mechanistic studies focused on cyclooxygenase (COX) isoform selectivity (COX-1 vs. COX-2).

Main Results:

• Dietary phytochemicals demonstrated a low potential for cardiovascular toxicity.
• Phytochemicals primarily inhibited cyclooxygenase-1 (COX-1), not COX-2.
• This inhibition pattern was dose-dependent, with COX-1 preference noted at lower concentrations.

Conclusions:

• Dietary phytochemicals appear safe regarding cardiovascular toxicity.
• The mechanism involves preferential inhibition of COX-1 over COX-2, similar to aspirin.
• This finding helps explain the lack of adverse cardiovascular events associated with lifelong phytochemical consumption.